Identification of integrin α3 as a molecular marker of cells undergoing epithelial-mesenchymal transition and of cancer cells with aggressive phenotypes

Cancer Science

Volumn 104, Issue 9, 2013, Pages 1189-1197

  Shirakihara, Takuya ^a   Kawasaki, Tomonori ^b   Fukagawa, Akihiko ^b   Semba, Kentaro ^c   Sakai, Ryuichi ^a   Miyazono, Kohei ^d   Miyazawa, Keiji ^b   Saitoh, Masao ^b  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c WASEDA UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ALPHA3 INTEGRIN; FIBROBLAST GROWTH FACTOR 2; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BREAST CANCER; CANCER CELL; CELL DIFFERENTIATION; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; MYOFIBROBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTOMICS; UPREGULATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELLS, CULTURED; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION PROFILING; HUMANS; INTEGRIN ALPHA3; MAP KINASE SIGNALING SYSTEM; MICE; MYOFIBROBLASTS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-RET; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84883464903     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12220     Document Type: Article

References (22)

1. Thiery JP, Acloque H, Huang RY, Nieto MA Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-90.
2. Miyazono KTransforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer. Proc Jpn Acad Ser B Phys Biol Sci 2009; 85: 314-23.
3. Saitoh M, Miyazawa K Transcriptional and post-transcriptional regulation in TGF-β-mediated epithelial-mesenchymal transition. J Biochem 2012; 151: 563-71.
4. Shirakihara T, Horiguchi T, Miyazawa M et al. TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition. EMBO J 2011; 30: 783-95.
5. Neve RM, Chin K, Fridlyand J et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006; 10: 515-27.
6. Horiguchi K, Sakamoto K, Koinuma D et al. TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP. Oncogene 2012; 31: 3190-201.
7. Saito D, Kyakumoto S, Chosa N et al. Transforming growth factor-β1 induces epithelial-mesenchymal transition and integrin alpha3beta1-mediated cell migration of HSC-4 human squamous cell carcinoma cells through Slug. J Biochem 2012; 153: 303-15.
8. Kondo M, Cubillo E, Tobiume K et al. A role for Id in the regulation of TGF-β-induced epithelial-mesenchymal transdifferentiation. Cell Death Differ 2004; 11: 1092-101.
9. DeFreitas MF, Yoshida CK, Frazier WA, Mendrick DL, Kypta RM, Reichardt LF Identification of integrin α3β1 as a neuronal thrombospondin receptor mediating neurite outgrowth. Neuron 1995; 15: 333-43.
10. Stine ZE, McGaughey DM, Bessling SL, Li S, McCallion AS Steroid hormone modulation of RET through two estrogen responsive enhancers in breast cancer. Hum Mol Genet 2011; 20: 3746-56.
11. Esseghir S, Todd SK, Hunt T et al. A role for glial cell derived neurotrophic factor induced expression by inflammatory cytokines and RET/GFR α1 receptor up-regulation in breast cancer. Cancer Res 2007; 67: 11732-41.
12. Boulay A, Breuleux M, Stephan C et al. The Ret receptor tyrosine kinase pathway functionally interacts with the ERα pathway in breast cancer. Cancer Res 2008; 68: 3743-51.
13. Rozzo C, Chiesa V, Ponzoni M Integrin up-regulation as marker of neuroblastoma cell differentiation: correlation with neurite extension. Cell Death Differ 1997; 4: 713-24.
14. Miyazaki K Laminin-5 (laminin-332): Unique biological activity and role in tumor growth and invasion. Cancer Sci 2006; 97: 91-8.
15. Kawataki T, Yamane T, Naganuma H et al. Laminin isoforms and their integrin receptors in glioma cell migration and invasiveness: Evidence for a role of α5-laminin(s) and α3β1 integrin. Exp Cell Res 2007; 313: 3819-31.
16. Wondimu Z, Omrani S, Ishikawa T et al. A novel monoclonal antibody to human laminin α5 chain strongly inhibits integrin-mediated cell adhesion and migration on laminins 511 and 521. PLoS ONE 2013; 8: e53648.
17. Shirakihara T, Saitoh M, Miyazono K Differential regulation of epithelial and mesenchymal markers by δEF1 proteins in epithelial mesenchymal transition induced by TGF-β. Mol Biol Cell 2007; 18: 3533-44.
18. Charafe-Jauffret E, Ginestier C, Monville F et al. Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 2006; 25: 2273-84.
19. Paumelle R, Tulasne D, Kherrouche Z et al. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway. Oncogene 2002; 21: 2309-19.
20. Gaggioli C, Hooper S, Hidalgo-Carcedo C et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 2007; 9: 1392-400.
21. Sachs N, Secades P, van Hulst L, Kreft M, Song JY, Sonnenberg A .Loss of integrin α3 prevents skin tumor formation by promoting epidermal turnover and depletion of slow-cycling cells. Proc Natl Acad Sci USA 2012; 109: 21468-73.
22. Suzuki N, Higashiguchi A, Hasegawa Y et al. Loss of integrin α3 expression associated with acquisition of invasive potential by ovarian clear cell adenocarcinoma cells. Hum Cell 2005; 18: 147-55.